ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 117 filers reported holding ENDOCYTE INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $488,400,000 | +20.0% | 27,500 | -6.8% | 0.00% | – |
Q2 2018 | $407,100,000 | +262545.2% | 29,500 | -13.0% | 0.00% | – |
Q3 2015 | $155,000 | -11.9% | 33,899 | 0.0% | 0.00% | – |
Q2 2015 | $176,000 | -17.0% | 33,899 | 0.0% | 0.00% | – |
Q1 2015 | $212,000 | -0.5% | 33,899 | 0.0% | 0.00% | – |
Q4 2014 | $213,000 | -97.9% | 33,899 | -92.2% | 0.00% | -100.0% |
Q1 2014 | $10,359,000 | +70.9% | 435,060 | -23.3% | 0.01% | +57.1% |
Q4 2013 | $6,062,000 | – | 567,060 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
Leisure Capital Management | 28,304 | $121,000 | 0.10% |
Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |